Search

everythinglearnresearchcommunity

for

Search:↓

Certain immune markers may predict chemotherapy response in mesothelioma, and nivolumab is a tolerable and effective treatment for advanced non-small cell lung cancer.

Canagliflozin helps overcome progestin resistance in certain endometrial cancer cells.

An 8-year-old with severe hair loss regrew all hair after six months of tofacitinib treatment.

Targeted therapy with Ustekinumab significantly improved a skin condition called ILVEN, which is caused by mutations in the CARD14 gene.

StemMACS media is better for growing therapeutic stem cells.

TNFα and interleukin-1 blockers reduce skin inflammation from EGFR antibody therapy.

Regenerative therapies like PRP and stem cells are promising for skin rejuvenation and repair.

Previous alopecia areata treatments do not affect the long-term effectiveness of ritlecitinib.

A man's hair regrew from alopecia areata after using tofacitinib and experiencing contact dermatitis from a wig device.

A patient's grey hair regained color during treatment with adalimumab.

A new microneedle patch effectively treats atopic dermatitis by reducing skin stress and restoring immune balance.

A woman's ovarian tumor causing high testosterone was successfully removed, and her symptoms improved.

Blocking certain proteins can reduce skin inflammation caused by cancer treatment.

Adalimumab significantly improves quality of life for patients with moderate to severe hidradenitis suppurativa.

Hormonal changes in skin may cause stretch marks.

JAK inhibitors are effective for long-term management of alopecia areata.

Ritlecitinib is the first FDA-approved pill for treating significant hair loss in alopecia areata patients aged 12 and up.

Trastuzumab may cause tufted hair folliculitis as a side effect.

Tranilast successfully treated a man's skin sarcoidosis when other treatments failed.

Ciclosporin can cause excessive hair growth even with testosterone blockers.

The new synthetic retinoid RO 13-6298 effectively treated severe psoriasis at low doses with manageable side effects.

Spironolactone and clascoterone are promising acne treatments with fewer side effects.

Using tazarotene with GliSODin improves facial skin more than tazarotene alone.

Cell therapy shows promise for treating severe psoriasis but needs more research to confirm safety and effectiveness.

Ritlecitinib helps reduce inflammation and promote hair regrowth in alopecia areata, especially in patchy-type cases.

Erlotinib causes skin inflammation through IL-1, which can be reduced by anakinra.

Alefacept does not effectively treat severe alopecia areata.